Figures
Abstract
Background
The zinc transporter ZIP4 (Slc39a4) is important for proper mammalian development and is an essential gene in mice. Recent studies suggest that this gene may also play a role in pancreatic cancer.
Methods/Principal Findings
Herein, we present evidence that this essential zinc transporter is expressed in hepatocellular carcinomas. Zip4 mRNA and protein were dramatically elevated in hepatocytes in the majority of human hepatocellular carcinomas relative to noncancerous surrounding tissues, as well as in hepatocytes in hepatocellular carcinomas occurring in farnesoid X receptor-knockout mice. Interestingly, meta-analysis of microarray data in the Geo and Oncomine databases suggests that Zip4 mRNA may also be elevated in many types of cancer. Potential mechanisms of action of ZIP4 were examined in cultured cell lines. RNAi knockdown of Zip4 in mouse Hepa cells significantly increased apoptosis and modestly slowed progression from G0/G1 to S phase when cells were released from hydroxyurea block into zinc-deficient medium. Cell migration assays revealed that RNAi knockdown of Zip4 in Hepa cells depressed in vitro migration whereas forced over-expression in Hepa cells and MCF-7 cells enhanced in vitro migration.
Citation: Weaver BP, Zhang Y, Hiscox S, Guo GL, Apte U, Taylor KM, et al. (2010) Zip4 (Slc39a4) Expression is Activated in Hepatocellular Carcinomas and Functions to Repress Apoptosis, Enhance Cell Cycle and Increase Migration. PLoS ONE 5(10): e13158. https://doi.org/10.1371/journal.pone.0013158
Editor: Xin-yuan Guan, The University of Hong Kong, China
Received: May 11, 2010; Accepted: September 10, 2010; Published: October 4, 2010
Copyright: © 2010 Weaver et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors were supported in part by National Institutes of Health (NIH) grants DK063975 (GKA); DK073446 (CS); DK080440 (LW); and DK081343 (GLG). BPW was funded in part by National Institutes of Health training grant T32ES007079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Zinc is essential for the structure and function of literally hundreds of proteins [1]. Therefore, changes in zinc availability alter numerous cellular processes. Multiple genes have evolved to control the storage (Metallothionein genes), efflux (Slc30a; Znt genes) and uptake (Slc39a; Zip genes) of this metal (Reviewed by [2]). Recent studies also reveal that zinc can be stored and released from intracellular vesicular compartments and can function as a novel intracellular second messenger [3], [4]. For example, zinc appears to be essential for lipopolysaccharide induced signal transduction in monocytes and to influence IFN-γ expression in activated T-cells, and in mast cells labile zinc plays a role in regulation of caspase activation and NF-κB translocation (Reviewed by [5]). In the brain, synaptically released zinc triggers a metabotropic signal [6]. Zinc can modulate the proliferation and differentiation of mammalian cells by affecting several growth factor signaling cascades [7]. The mechanism by which zinc exerts these effects is an area of active investigation. Zinc can affect signal recognition, second messenger metabolism, protein kinase and protein phosphatase activities and transcription factor activity [5], [8]–[10].
Given the diversity of functions of zinc it is perhaps not surprising that zinc transporters have recently been found to play roles in carcinogenesis [2], [10], [11], as well as in embryonic development (Reviewed by [12]). For example, ZIP1, ZIP4, ZIP6, ZIP7 and ZIP10, members of the Zrt-Irt-like protein (Slc39a) superfamily [2], have each been implicated in specific cancers. ZIP1 is repressed in prostate cancer [11]. Aberrant accumulation of ZIP4 has been reported to contribute to the progression and aggressiveness of pancreatic cancer [13]–[16]. ZIP6 and ZIP7 may play roles in metastasis of estrogen receptor-positive breast cancer [10], [17] as well as in the proliferation, migration and invasion of cervical cancer [18]. Similarly, ZIP10 has been shown to affect the invasive behavior of breast cancer cells [19]. With regard to embryonic development, mutations in human ZIP4 cause the lethal genetic disorder of zinc metabolism acrodermatitis enteropathica, and the mouse Zip4 gene is essential for proper early morphogenesis of the mouse embryo [20], [21]. To date Zip4 is the only mammalian ZIP superfamily member which has been shown to be an essential gene; one that plays a fundamental role in adaptation to zinc deficiency. However, the fear-of-intimacy gene in Drosophila encodes a ZIP6-like zinc transporter that is essential during early development and plays a role in migration of germ cells [22]. Similarly, in zebrafish, a member of the ZIP superfamily (zLIV-1) is essential during early morphogenesis and plays a role in the epithelial-mesenchymal transition (EMT) during gastrulation [23].
Given the fundamental role of ZIP4 in mammalian development and adaptation to zinc deficiency, and the recent report of its role in pancreatic cancer, we examined whether this gene may play a fundamental role in carcinogenesis. Herein, we report that the Zip4 gene is also actively expressed in hepatocytes in human and mouse hepatocellular carcinomas (HCC), and meta-analyses of the Geo and Oncomine databases further suggested that enhanced expression of the Zip4 gene may occur in many different cancers. We present evidence that ZIP4 can repress apoptosis and enhance cell-cycle and cell migration. Therefore, ZIP4 can exert profound effects on cancer growth and metastasis.
Results
The Zip4 Zinc Transporter Gene is Activated in Human and Mouse Hepatocellular Carcinomas and May Also be Activated in Many Different Cancers
We examined the expression of Zip4 in human hepatocellular carcinomas (HCC). RNA extracted from a panel of biopsies of human HCC and surrounding control tissue was analyzed by real-time quantitative RT-PCR for Zip4 mRNA and values were normalized to GAPDH mRNA (Table 1). Of the cancers examined, 16 of 23 had elevated levels (>2-fold) of Zip4 mRNA compared with surrounding control tissue and in several of the HCC samples Zip4 mRNA was dramatically elevated (10- to 77-fold). Similar results were obtained by normalizing Zip4 mRNA values with those of another internal control HPRT1 mRNA values (data not shown). The presence of ZIP4 protein in human HCC was confirmed by immunofluorescence detection in frozen sections (Fig. 1A). Cancerous tissues stained intensely for ZIP4 whereas surrounding cells and normal liver did not (Fig. 1A; see normal liver tissue 3 and Patient 3). Many hepatoadenoma/carcinoma cells within tumor tissues stained very intensely for ZIP4 (Fig. 1A; see top left panel, Patient 4). ZIP4 was also detected in hepatocytes from several of the samples which did not appear to have elevated Zip4 mRNA (see Fig. 1; patient 11). Histological examination of liver sections from patients 3 and 4 (Fig. 1B) confirmed that ZIP4 positive cells were within well-circumscribed lesions which primarily contained hepatoadenoma/carcinoma cells, although we cannot exclude the possibility that some other cell-types may also express Zip4 in these tumors.
Part A: Frozen sections of HCC from patients 3, 4 and 11 and normal liver tissue from patient 3 (see Table 1) were fixed, permeablized and blocked then ZIP4 was detected using an antipeptide antibody against mouse ZIP4 [26], [47]. The peptide immunogen is well conserved between mouse and human and specificity of this antibody has been established [26], [27], [46]. Sections were washed and incubated sequentially with biotinylated secondary antibody then QDot 655 streptavidin conjugate. Red indicates the presence of ZIP4 whereas blue indicates nuclei stained with DAPI. Adobe Photoshop image capture software was used to capture these images. Part B: Frozen serial sections from patients 3 & 4 stained with hematoxylin and eosin to reveal the cellular structure of the ZIP4 positive tumors. Arrows point to the boundary of well-circumscribed lesions containing ZIP4 positive hepatocytes.
Expression of Zip4 in a mouse model of HCC was also examined, using FXR-knockout mice. FXR is a nuclear receptor essential for maintaining bile acid homeostasis. The FXR-knockout mice show increased bile acids and liver injury [24]. FXR deficiency in mice results in spontaneous liver carcinogenesis with hepatic adenoma, adenocarcinoma, and cholangiocyte carcinoma when reaching 8 to 10 months of age in both genders [24], [25]. In FXR-knockout mice older than 12 months, the incidence of liver tumor is 100% with the majority of the tumors being hepatocellular adenoma followed by hepatocellular carcinoma. The hepatocellular adenomas are characterized as well-circumscribed lesions with well-differentiated hepatocytes, whereas the hepatocellular carcinoma consist of both hepatocellular and cholangiocellular components.
Northern blot hybridization of RNA from normal liver and tumors from these mice (15 months old) revealed high levels of Zip4 mRNA in 4 out of 5 of the tumor samples and the abundance of this mRNA in those tumors was similar to that found in mouse Hepa cells. In contrast, Zip4 mRNA was rare in the normal liver samples (Fig. 2A) as reported previously [26]. The presence of ZIP4 protein in mouse HCC was confirmed by immunohistochemical detection in paraffin sections (Fig. 2B). Groups of cells staining intensely for ZIP4 were readily detected in all 5 tumor samples (one is shown in Fig. 2B), but no ZIP4 staining was detected in sections of normal liver (Fig. 2B; top panels) or in the cells surrounding the tumors in FXR-knockout mice (Fig. 2B; bottom panels). ZIP4 localization was restricted to the plasma membrane of hepatocytes within well-circumscribed lesions suggesting that these were hepatocellular adenomas (Fig. 2B). The majority of hepatocytes within these lesions displayed ZIP4 localization restricted to what appears to be the apical surface juxtaposed to a lumen, suggesting that these are well differentiated hepatocytes (Fig. 2B).
Part A: HCC from FXR-knockout mice (FXR KO; 15 months of age) and normal liver from wild-type (WT) litter mates were analyzed by Northern blot hybridization to detect Zip4 mRNA in total RNA. Actin mRNA served as a loading control in the Northern blots and staining of 28S and 18S rRNA served as a control for integrity and quantity of RNA loaded. Part B: Immunohistochemical detection of ZIP4 in paraffin sections of HCC from FXR-knockout and wild-type mice. Arrow is pointing to the boundary of a well-circumscribed lesion containing ZIP4-positive hepatocytes in the FXR-knockout liver. Brown deposits indicate ZIP4 staining. Blue color indicates hematoxylin stained nuclei.
The finding that Zip4 is aberrantly expressed in human and mouse HCC, as well as in pancreatic adenocarcinoma, suggested that Zip4 expression might also be increased in other carcinomas. A meta-analysis of microarray data deposited in the Geo and Oncomine databases for Zip4 (Slc39a4) expression supported this hypothesis (Table 2). In the Geo database many Slc39a4 data sets did not reveal significant differences between normal and cancer samples, but evidence suggested elevated Zip4 mRNA is found in some lymphoma, melanoma and metastatic colon cancer data sets and in data sets from two mouse models of HCC (Mdr2 knockout and Trnip transgenic). In the Oncomine database Zip4 was found to be among the top 10% of genes expressed in many human cancer types and was often associated with an aggressive stage of the cancer. Expression in human HCC was also confirmed. This meta-analysis suggests, but does not prove, that active expression of Zip4 may occur in many different carcinomas. However, these analyses did confirm and extend our independent finding of active Zip4 expression in HCC from humans and mice.
Expression of the Zip4 Gene Reduces Apoptosis, Modestly Enhances Reentry into the Cell Cycle after G0/G1 Block When Zinc is Deficient, and Enhances Cell Migration
To examine the functions of ZIP4 in HCC, we determined the effects of Zip4 knockdown on apoptosis and progression through the cell cycle in mouse Hepa cells. These cells actively express the Zip4 gene and regulate the stability of this mRNA and the endocytosis and processing or turn-over of this protein in response to zinc [27], [28]. ZIP4 protein is present at a low level in Hepa cells under zinc-adequate culture conditions but accumulates during zinc-deficiency (Fig. 3). Mouse Hepa cells were infected with lentivirus vectors which express two RNAi sequences against mouse Zip4 mRNA or a scrambled control RNAi, and infected cells were purified by FACS using GFP expression from the viral vector. Western blot analysis of membrane proteins from these cells revealed that Zip4 RNAi effectively reduced ZIP4 protein levels and largely prevented induction in response to zinc-deficient culture conditions, but had no effect on ZIP1 abundance (Fig. 3). The control RNAi did not alter ZIP4 abundance or effect induction of this protein during zinc-deficiency (Fig. 3).
RNAi (two RNAi sequences) against mouse Zip4 (Z4) and a scrambled RNAi control (Con) were expressed from the U6 promoter in lentivirus vectors that also express GFP driven by the PGK promoter. Cells were infected and then purified for GFP expression by FACS. Lentivirus infected cells and uninfected Hepa cells (-) were then cultured for 24 hr in zinc-adequate medium (N) which contains normal FBS or zinc-deficient medium (CX) which contains Chelex-treated FBS. Membrane preparations from these cells were then fractionated by SDS-PAGE, transferred to a membrane, and ZIP4 was detected using an antipeptide antibody against mouse ZIP4. A prominent ∼73 kDa ZIP4 band was detected (predicted size) as well as a larger ZIP4 aggregate. ZIP1 was detected as a loading control (bottom panel). In Hepa cells a non-specific (NS) band, which is predominately cytosolic, was detected in these membrane preparations.
Zip4 RNAi and control RNAi Hepa cells, purified by flow sorting, were seeded at low density to facilitate a rapid onset of zinc deficiency, blocked using hydroxyurea to increase the number of cells in G0/G1, and then released from the block to reinitiate the cell cycle in zinc-deficient medium (Fig. 4). The number of cells in the various parts of the cell cycle was monitored by FACS at various times up to 24 hr (Table 3). After release from the hydroxyurea block into zinc-adequate medium, Zip4 RNAi and control RNAi Hepa cells both progressed through the cell cycle at essentially indistinguishable rates (data not shown). In contrast, when released into zinc-deficient medium, cells expressing Zip4 RNAi reentered the cell cycle more slowly than did those expressing control RNAi. At every time point examined the percentage of cells in S phase after release from the block was lower in the Zip4 RNAi cells compared with the control RNAi cells (Fig. 4B) while the percentage of cells in G2 was greater in the Zip4 RNAi cells compared with the control RNAi cells (Fig. 4B & C and Table 3). These data suggest that Zip4 expression enhances cell cycle in Hepa cells. In addition to these findings, cultures expressing Zip4 RNAi displayed a 2 to 3-fold increase in the sub-G1 fraction, indicative of apoptotic cells with fragmented nuclear DNA [29], after release into zinc-deficient medium (Fig. 4D and Table 3). In contrast to these results, expression of Zip4 RNAi or control RNAi did not affect reentry into the cell cycle after a G2/M block using nocodazole, regardless of whether cells were released into zinc-adequate or zinc-deficient medium (data not shown).
Hepa cells expressing Zip4 RNAi (Z4 RNAi) or control RNAi (Con RNAi) from lentivirus vectors were purified for GFP expression by FACS. Confluent cultures were replated at low density (1∶10) in zinc-deficient medium (DMEM plus 10% Chelex-treated FBS), and blocked overnight in G0/G1 using hydroxyurea. The medium was replaced with fresh zinc-deficient medium and progression through the cell cycle was quantified at the indicated times after release. Cell cycle parameters were monitored by propidium iodide staining followed by FACS. The percentage of cells in each phase of the cell cycle is presented within each FACS scan. Part A: Cells in G0/G1. Part B: Cells in S phase. Part C: Cells in G2/M. Part D: Cells in the sub-G1 fraction which is indicative of apoptotic cells. Data are expressed as the mean ± S.D. *Indicates a significant difference between Zip4 RNAi and control RNAi (P<0.001).
The potential functions of ZIP4 in hepatoma cells was investigated using Hepa cells that express control RNAi or Zip4 RNAi, as well as these cells transiently transfected with a human Zip4 cDNA expression vector encoding human ZIP4 with a carboxyl-terminal HA tag (Fig. 5A & B). Human Zip4 mRNA would not be targeted efficiently by the RNAi against mouse Zip4. Forced expression of Zip4 has been recently reported to increase cell proliferation, tumor volume and metastasis of pancreatic cells in vivo [13]. Herein, the ability of Hepa cells to migrate through a fibronectin-coated membrane was monitored. Hepa cells expressing control RNAi migrated through membranes more efficiently than did those expressing Zip4 RNAi (Fig. 5A &B). Forced expression of human Zip4-HA in Hepa cells enhanced migration. Expression of human Zip4-HA in Hepa cells which also express Zip4 RNAi against mouse Zip4 restored migration activity, whereas it further augmented migration activity of Hepa cells expressing control RNAi. In parallel experiments we employed a well-established system using MCF-7 breast cancer cells which display a low background of cell migration in vitro [30]. In these cells, expression of Zip7 has been shown to enhance migration [31] and Zip4 is not expressed at significant levels [32]. Herein, MCF-7 cells were transiently transfected with an expression vector for mouse Zip4 with a carboxyl-terminal HA tag [33]. The results show that forced expression of mouse Zip4 also increased the migration of MCF-7 cells under these experimental conditions (Fig. 5C). These transfection experiments underestimate the effects of forced expression of mouse or human Zip4-HA since all of the cells were not transfected in these cultures. Taken together the above results demonstrate that ZIP4 can enhance cell migration.
Hepa cells expressing Zip4 RNAi (Z4 RNAi) or control RNAi (Con RNAi) from lentivirus vectors were purified for GFP expression by FACS. Cells were seeded onto fibronectin-coated Transwell inserts and allowed to migrate for a period of 16 h. Non-migratory cells were removed and cells that had migrated through the membrane were fixed and stained with crystal violet. Cell migration was visualized by microscopy (Part A) and quantified by measuring the absorbance of cell lysates at 595 nm (Part B). In parallel, Hepa cells expressing Zip4 RNAi or control RNAi were transfected with a human Zip4-HA expression vector (Z4HA), serum starved overnight and then seeded onto Transwell inserts and allowed to migrate for 16 h. Migratory cells were visualized and quantified as described above. ** Indicates a significant difference from control RNAi and/or Z4 RNAi, left two bars (P<0.001) and # indicates a significant difference from control RNAi and/or Z4 RNAi/Z4HA (P<0.001). Part C: MCF-7 cells were transfected with an expression vector for mouse Zip4-HA [33] (Z4HA), or exposed to transfection reagent without vector (control), and then seeded onto fibronectin-coated Transwell inserts. Cells were allowed to migrate for a period of 16 h, non-migratory cells were removed and cells that had migrated through the membrane were fixed and stained. Cell migration was quantified by counting the numbers of cells in 5 randomly-chosen fields of view per membrane (n≥3 for each treatment) and results are plotted as the mean cell migration (percent of control ± S.D.). ** Indicates a significant difference between control and Z4HA transfected MCF-7 cells (P<0.001).
Discussion
Studies reported herein demonstrate that the essential zinc transporter ZIP4 is actively expressed in hepatocellular carcinoma (HCC) and may well be expressed in many other types of cancer. HCC is the fifth most common cancer in the world and third leading cause of cancer deaths resulting in over 600,000 deaths globally per year. The 5 year survival rate is reported to be below 5% (Reviewed by [34]). Thus, the finding of constitutively high levels of Zip4 mRNA and protein in HCC, as well as in many cancers in humans, is intriguing and may represent a potential therapeutic target. Taken together with the recent demonstration that ZIP4 is aberrantly expressed in pancreatic carcinoma [13], our finding that Zip4 mRNA and protein also accumulate in HCC suggests that aberrant activation of the Zip4 gene may play a fundamental role in tumorigenesis.
How expression of the Zip4 gene is turned-on in cancer cells is unknown. Active Zip4 gene expression is normally highly cell-type specific [26], although very low level expression in some cultured cells has been detected by RT-PCR [35]. In the normal mouse liver Zip4 mRNA is rare and unresponsive to dietary zinc [26], [27]. In contrast, Zip4 mRNA abundance and protein stability are both regulated by several zinc-dependent post-transcriptional mechanisms in cells that actively express this gene (enterocytes, visceral endoderm, Hepa cells) [36]. Both mRNA and protein abundance are repressed when zinc is replete, whereas accumulation of ZIP4 protein at the apical surface of enterocytes and visceral endoderm cells and accumulation of Zip4 mRNA occurs when zinc is deficient. The finding that ZIP4 localizes to what appears to be the apical surface of hepatocytes in the liver tumors from FXR-knockout mice suggests that either this protein is not zinc-regulated in those cells or that these cells are zinc deficient. Several studies have reported that HCCs have significantly lower levels of zinc than the surrounding tissues (Reviewed by [34]) which is consistent with the latter hypothesis. Whether this may also be the case for other cancers which may express ZIP4 is not known. Aberrant expression of Zip4 has been previously documented in pancreatic ductal carcinoma, but the localization of ZIP4 in those cancers was not reported [13].
Our studies revealed that when zinc is deficient ZIP4 functions to repress apoptosis and may enhance reentry of hepatoma cells into the cell cycle following release from a G0/G1 block. How ZIP4 exerts these functions can be deduced from the fact that ZIP4 is essential for the acquisition of dietary zinc in humans, and for the transfer of zinc into the post-implantation conceptus and for resistance to zinc deficiency in mice [20]. Therefore, ZIP4 likely serves a fundamental role to facilitate zinc uptake in some tumors. Pancreatic cancer cells that over-express ZIP4 have higher zinc levels than do normal pancreatic cells and display increased in vitro proliferation and growth in nude mice [13]. A relationship between zinc, apoptosis and cell proliferation has been known for over 15 years [37]–[39]. Zinc can regulate caspases and apoptosis in a cell-type and concentration dependent manner [11]. Zinc deficiency can increase DNA damage and alter the expression of genes involved in cell cycle, apoptosis and DNA damage response and repair [38], as well as cause increased apoptosis in developing rat embryos [40] and in the skin [41]. Increased zinc stimulates DNA synthesis in embryonic stem cells [42] and attenuates apoptosis in human hepatoma cells in culture [43]. Taken together these findings support the concept that ZIP4 facilitates zinc uptake which, in turn, enhances DNA replication and repair and reduces apoptosis. Consistent with this concept knockdown of Zip4 using RNAi in pancreatic cancer cells inhibited their growth in nude mice [14]. Other zinc transporters may serve the function of zinc uptake in some cancers.
Forced expression of either human or mouse Zip4 was found herein to enhance the in vitro migration of Hepa cells and MCF-7 cells, respectively. In contrast, repressed expression of Zip4 attenuated in vitro migration of Hepa cells. These findings are consistent with recent reports that forced expression of Zip4 in pancreatic cancer cells increases tumor volume and metastasis in nude mice [13], whereas knockdown of Zip4 in pancreatic cancer cells is associated with decreased cell proliferation, migration and invasion [14]. Taken together these studies provide strong support for the concept that ZIP4 serves a fundamental role in cancer.
The molecular mechanisms by which ZIP4 and zinc control growth and migration of cancer cells likely involves multiple signal transduction cascades. The effects of zinc and zinc transporters on signal transduction cascades appear to be, in part, cell-type specific. For example, mutations in ZIP13 cause a rare form of Ehlers-Danlos syndrome, and result in abnormal development of connective tissues possibly due to changes in signaling through the bone morphogenic protein/TGFβ signaling cascade [44]. In HeLa cells Zip6 over-expression enhances SNAIL, a repressor of E-cadherin [18] and in Zebrafish zLIV-1 (ZIP6-like) regulates SNAIL and enhances the epithelial-mesenchymal transition during development [23]. Recent studies of pancreatic cancer reported that ZIP4 activates the IL-6/Stat3 pathway via CREB, leading to increased expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases [15], [16]. Zinc has been shown to modulate FoxO signaling in human hepatoma cells [43] and in mouse embryonic stem cells zinc stimulates DNA synthesis through the PI3K/Akt, MAPKs and mTOR pathways [42]. We noted that zinc availability can control the abundance of β-catenin in two hepatoma cell lines [Weaver and Andrews, unpublished observation]. Thus, ZIP4 enhanced zinc uptake may affect signal recognition, second messenger metabolism, protein kinase and protein phosphatase activities and transcription factor activity (Reviewed by [5], [10]). Whether ZIP4 has functions in addition to zinc uptake activity remains to be determined and further studies are required to delineate the mechanisms by which ZIP4 and other ZIP family members can alter signal transduction cascades in cancer cells.
Materials and Methods
Ethics Statement
All experiments involving mice were conducted in accordance with the National Institutes of Health guidelines for the care and use of experimental animals and were approved by the Institutional Animal Care and Use Committee (ACUP number 2007-1698: approved 1-19-2010).
Human HCC Specimens
HCC specimens were obtained through the LTCDS (Liver Tissue Cell Distribution Service) under the NIH Contract – #N01-DK-7-0004/HHSN267200700004C (Minneapolis, Minnesota) [45].
Real-Time PCR Quantification of Zip4 mRNA in Human HCC
Total RNA was isolated from tumor and surrounding normal tissue by Trizol extraction. Real-time PCR was performed using total RNA and products were detected using the SYBR Green PCR master mix (appliedbiosystems.com). PCR included the following components: 100 nM of each primer, diluted cDNA templates and SYBR green PCR master mix. Samples were denatured at 95°C for 10 min and amplified for 40 cycles at 95°C for 15 sec and 60°C for 1 min. The melting-curve data were collected to confirm PCR specificity. Each cDNA sample was run in triplicate, and the corresponding no-reverse transcriptase (RT) mRNA sample was included as a negative control. The GAPDH primers were included in every sample to control for sample variation. Zip4 mRNA product in each sample was normalized to that of the GAPDH mRNA. The amount of PCR products was measured by threshold cycle (Ct) values and relative mRNA levels are presented as unit values of 2̂[Ct(GAPDH) -Ct(Zip4)]. The primer sequences for human Zip4 mRNA (Slc39a4) were: sense 5′ AAGCACTGCTGCTGAACCTGGCCT 3′; and antisense 5′ GATGTCATCCTCGTACAGGGACAGCAGC 3′. The primer sequences for the human GAPDH mRNA were: sense 5′ ACATCATCCCTGCCTCTACTGG 3′; and antisense 5′ TCCGACGCCTGCTTCACC 3′.
Immunofluorescence and Immunohistochemical Detection of ZIP4, and Histology of Human HCC Tissue
Frozen sections of human HCC and normal liver were thawed directly into phosphate-buffered saline (PBS) containing freshly prepared 2% paraformaldehyde and 0.1% Triton-X-100 for 30 min at room temperature. Sections were washed with PBS and incubated in PBS containing 50 mM lysine for 30 min to quench autofluorescence. Sections were washed in PBS, incubated in PBS containing 0.1% Triton-X-100/0.1% Tween 20 for 20 min, blocked with 10% normal goat serum in PBS for 1 hr and ZIP4 was detected, as described previously, using an antipeptide antibody against mouse ZIP4 [26]. The peptide immunogen is well conserved between mouse and human and specificity of this antibody has been established [26], [27], [46]. Sections were washed thoroughly with PBS and incubated sequentially with biotinylated secondary antibody (1∶500; jacksonimmuno.com) and QDot 655 streptavidin conjugate (1∶500; invitrogen.com). Slides were mounted with glycerol containing 4′,6-diamidino-2-phenylindole (DAPI) to stain nuclei and visualized using a Leica DM 4000B (Leica-microsystems.com) with Adobe Photoshop image capture software (adobe.com). For histology of human HCC, frozen serial sections from tissues assayed by immunofluorescence (above) were thawed directly in PBS containing freshly prepared 4% paraformaldehyde, washed in PBS, stained with hematoxylin and eosin and photographed using a Leica DM 4000B, as above.
Immunohistochemistry was employed to detect ZIP4 in FXR-knockout mouse livers and normal liver using the Zymed Laboratories Inc. Histostain-SP kit (invitrogen.com) for rabbit primary antibody and diaminobenzidine substrate staining, as described previously [47]. Tissues were fixed overnight in 4% paraformaldehyde, embedded in paraffin, and sectioned. Sections were deparaffinized, and subjected to antigen retrieval in 10 mM citrate (pH 6.0) at 95°C for 10 min. Sections were then treated with 1% peroxide, blocked with 10% normal goat serum, and incubated with the primary antiserum (1∶600 dilution). Sections were washed with PBS, incubated with biotinylated secondary antibody followed by streptavidin-conjugated horseradish peroxidase and then developed in diaminobenzidine. Slides were then stained with hematoxylin and photographed using a Leica DM 4000B with Adobe Photoshop image capture software.
A Farnesoid X Receptor (FXR)-Knockout Mouse Model of HCC
The FXR-knockout mice were generated and back-crossed into the C57BL/6 genetic background, as described previously [24]. The genotype was confirmed by a PCR-based genotyping protocol. Mice were allowed free access to water and food and were exposed to a 12 hr light/12 hr dark cycle. Livers were removed from 15-month old male mice and snap-frozen in liquid nitrogen or frozen in OCT-compound.
Northern Blot Hybridization
Total RNA (3–6 µg) was isolated, size-fractionated by agarose-formaldehyde gel electrophoresis and transferred and UV cross-linked to nylon membranes, as described in detail previously [48], [49]. Northern blot membranes were hybridized and washed under stringent conditions. Hybrids were detected by autoradiography at −80°C. Duplicate gels were stained with acridine orange to ensure equivalent loading and integrity of total RNA. Probes for mouse Zip4 and actin mRNAs were as described [47]. Probes were used at 2×106 cpm/ml of hybridization solution.
Zinc-Adequate and Zinc-Deficient Cell Culture Conditions
Mouse Hepa cells were maintained at 37°C in a humidified 5% CO2 incubator in Dulbecco's modified Eagle medium (DMEM) containing 10% heat-inactivated fetal bovine serum (FBS), 100 units penicillin/ml, and 100 µg streptomycin/ml. To generate zinc-deficient conditions in culture, heat-inactivated fetal bovine serum (FBS) was treated with Chelex-100 resin, as described [33]. Essential metals except zinc were repleted by the DMEM which was adjusted to 10% Chelex-treated FBS. Cells were plated at a density of 5×104 cells per 10 cm plate in either zinc-adequate (normal FBS) or zinc-deficient (Chelex-treated FBS) medium.
Zip4 RNAi Lentivirus Construction
Zip4 RNAi and control RNAi lentiviral constructs were created in third generation lentiviral vectors, amplified in HEK293 cells, purified by centrifugation, and titered in the Washington University Core Facility as described [50]. The packaging genes were separated on two plasmids which lack both LTRs and have no viral packaging signal. The following viral genes were deleted from the packaging vector: env, vpr, vpu, vif and nef. This vector has a self-inactivating LTR and envelope, VsVg, is expressed on a separate plasmid [51]. The RNAi against mouse Zip4 and the scrambled RNAi control were expressed from the U6 promoter; this vector also expressed green fluorescence protein (GFP) driven by the PGK promoter. The oligos listed below were annealed, phosphorylated, and ligated into this vector just downstream of the U6 promoter at the AarI site.
Zip4 RNAi
Lentivirus Infection and Purification of Mouse Hepa Cells
Mouse Hepa cells were incubated with Zip4 RNAi and control RNAi lentiviruses at a multiplicity of infection of 5∶1 overnight. Cells were washed extensively and then incubated for 24 hr in DMEM containing 10% FBS. A single cell suspension of these cells was prepared in PBS containing 20% FBS and analyzed by fluorescence activated cell sorting (FACS) for GFP expressed from the lentivirus construct. Fluorescence in the GFP channel was monitored and the intensity of autofluorescence in the wild-type cells was used to define the base line fluorescence. Cells with signal intensities clearly greater than that value were collected and used for experiments. At least 95% of the flow sorted cells were GFP positive.
Western Blot Detection of ZIP4
Membrane proteins were prepared from Hepa cells and analyzed as described [27], [47]. Membrane proteins (20 to 25 µg) were resolved by 8% SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to polyvinylidene difluoride membranes. Membranes were blocked overnight and then incubated with primary antibody in blocking solution at the appropriate dilution (ZIP4 antiserum 1∶800; ZIP1 antiserum 1∶800) for 2 hr at room temperature. After extensive washing, membranes were incubated with goat anti-rabbit horseradish peroxidase-conjugated secondary antibody and the blot was developed using ECL Plus reagent (amershambiosciences.com) according to manufacturer's instructions and detected using Kodak BioMax MS film (kodak.com).
Cell Cycle Analysis by FACS
Hepa cells expressing Zip4 RNAi or control RNAi were split 1∶10 from confluent cultures into zinc-adequate or zinc-deficient medium and then blocked in G0/G1 by incubating for 16 hr with 100 mM hydroxyurea (sigmaaldrich.com) or blocked in G2/M by incubating for 16 hr with 0.1 µg/ml nocodazole (sigmaaldrich.com). The blocking medium was then replaced with zinc-adequate or zinc-deficient medium to allow cells to progress in the cell cycle, and cells were harvested at different times thereafter. Cell cycle parameters were monitored by propidium iodide (PI) staining followed by FACS using an Epics XL Flow Cytometer (beckman.com) [52].
ZIP4 and Cell Migration Assay
Hepa cells expressing Zip4 RNAi or control RNAi were plated onto 60 mm dishes and transfected with 4 µg of a human Zip4-HA expression vector or pcDNA3.1 control vector using Lipofectamine 2000 (invitrogen.com) in antibiotic free media according to the manufacturer's instructions. After 6 h the cells were serum starved for 24 h and 5×104cells were seeded onto Transwell inserts (8 µm pore size; Culterx 96 well cell migration assay: amsbio.com). Cells were allowed to migrate for 16 h after which the non-migratory cells were removed from inside the chamber with a cotton swab. Cells that had migrated through the membrane pores were fixed for 10 min (3.7% v/v formaldehyde in PBS), stained with 0.1% crystal violet for 15 min, washed with PBS, and photographed using a Microfire/Qcam CCD Olympus 1×81 microscope. Crystal violet stained cells were lysed in 1% SDS for 30 min and absorbance of the lysate was measured at 595 nm in a plate reader (BioTek, synergy HT: biotek.com). Results were plotted as the mean absorbance ± S.D.
MCF-7 cells were seeded at 2×105/cm2 and grown until 80% confluent in phenol-red-free RPMI supplemented with 5% fetal calf serum, 200 mM L-glutamine, 10 IU/ml penicillin, 10 µg/ml streptomycin, and 2.5 µg/ml fungizone. Cells in 60 mm dishes were transfected with 8.8 µg of an expression vector for mouse Zip4-HA [33] and 27.5 µl of Lipofectamine 2000 (invitrogen.com) in antibiotic free media according to the manufacturer's instructions. As a control, cells were exposed to Lipofectamine 2000 without expression vector. After 6 hr the cells were counted and 2×104 cells were seeded onto fibronectin-coated (1 µg/ml) Transwell inserts (8 µm pore size; bdbiosciences.com). Cells were allowed to migrate for a period of 16 h after which the non-migratory cells were removed from inside the chamber with a cotton swab. Cells that had migrated through the membrane pores were fixed (3.7% v/v formaldehyde in PBS) and stained with crystal violet. Cell migration was quantified by counting the numbers of cells in 5 randomly-chosen fields of view per membrane (n≥3 for each treatment) and results were plotted as the mean cell migration (percent of untreated cells ± S.D.).
Meta-Analyses of Zip4 mRNA Microarray Data Deposited in the Geo and Oncomine Public Databases
The Geo microarray database at the NCBI was accessed at the following URL: http://www.ncbi.nlm.nih.gov/geo. This database was queried for Gene Profile of Slc39a4 and cancer, at the time of submission of this manuscript, which yielded 106 hits; Slc39a4 and hepatocellular carcinoma which yielded 5 hits; Slc39a4 and lymphoma which yielded 21 hits, Slc39a4 and colon cancer which yielded 5 hits; and Slc39a4 and melanoma which yielded 18 hits. Among these data sets several cancers which showed increased expression of Zip4 mRNA were noted. The Oncomine database was accessed at the following URL: http://www.oncomine.org. This database was queried for Slc39a4 among the top ten percent of genes expressed in tumors.
Acknowledgments
We thank Jim Geiser for excellent technical assistance and Dr. Joyce Slusser for FACS analyses at the KUMC FACS facility.
Author Contributions
Conceived and designed the experiments: BPW YZ SH GLG UA KMT CTS LW GKA. Performed the experiments: BPW YZ SH. Analyzed the data: BPW YZ SH GLG UA KMT CTS LW GKA. Contributed reagents/materials/analysis tools: SH GLG UA CTS LW. Wrote the paper: BPW YZ GLG UA KMT CTS LW GKA.
References
- 1. Berg JM, Shi YG (1996) The galvanization of biology: A growing appreciation for the roles of zinc. Science 271: 1081–1085.
- 2. Lichten LA, Cousins RJ (2009) Mammalian Zinc Transporters: Nutritional and Physiologic Regulation. Annu Rev Nutr 29: 153–176.
- 3. Devirgiliis C, Murgia C, Danscher G, Perozzi G (2004) Exchangeable zinc ions transiently accumulate in a vesicular compartment in the yeast Saccharomyces cerevisiae. Biochem Biophys Res Commun 323: 58–64.
- 4. Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K (2007) Zinc is a novel intracellular second messenger. J Cell Biol 177: 637–645.
- 5. Haase H, Rink L (2009) Functional Significance of Zinc-Related Signaling Pathways in Immune Cells. Annu Rev Nutr 29: 133–152.
- 6. Besser L, Chorin E, Sekler I, Silverman WF, Atkin S, et al. (2009) Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J Neurosci 29: 2890–2901.
- 7. Beyersmann D, Haase H (2001) Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 14: 331–341.
- 8. Haase H, Maret W (2005) Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases. J Trace Elem Med Biol 19: 37–42.
- 9. vonBulow V, Dubben S, Engelhardt G, Hebel S, Plumakers B (2007) Zinc-Dependent Suppression of TNF-{alpha} Production Is Mediated by Protein Kinase A-Induced Inhibition of Raf-1, I{kappa}B Kinase beta, and NF-{kappa}B. J Immunol 179: 4180–4186.
- 10. Hogstrand C, Kille P, Nicholson RI, Taylor KM (2009) Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol Med 15: 101–111.
- 11. Franklin RB, Costello LC (2009) The important role of the apoptotic effects of zinc in the development of cancers. J Cell Biochem 106: 750–757.
- 12. Kambe T, Weaver BP, Andrews GK (2008) The genetics of essential metal homeostasis during development. Genesis 46: 214–228.
- 13. Li M, Zhang Y, Liu Z, Bharadwaj U, Wang H (2007) Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A 104: 18636–18641.
- 14. Li M, Zhang Y, Bharadwaj U, Zhai QJ, Ahern CH (2009) Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res 15: 5993–6001.
- 15. Zhang Y, Bharadwaj U, Logsdon CD, Chen C, Yao Q, et al. (2010) ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res 16: 1423–1430.
- 16. Zhang Y, Chen C, Yao Q, Li M (2010) ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol Ther 9: 236–242.
- 17. Taylor KM, Hiscox S, Nicholson RI (2004) Zinc transporter LIV-1: a link between cellular development and cancer progression. Trends Endocrinol Metab 15: 461–463.
- 18. Zhao L, Chen W, Taylor KM, Cai B, Li X (2007) LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1/2-Snail/Slug pathway. Biochem Biophys Res Commun 363: 82–88.
- 19. Kagara N, Tanaka N, Noguchi S, Hirano T (2007) Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells. Cancer Sci 98: 692–697.
- 20. Dufner-Beattie J, Weaver BP, Geiser J, Bilgen M, Larson M, et al. (2007) The mouse acrodermatitis gene Slc39a4 (ZIP4) is essential for development and heterozygosity causes hypersensitivity to zinc deficiency. Hum Mol Genet 16: 1391–1399.
- 21. Schmitt S, Kury S, Giraud M, Dreno B, Kharfi M, et al. (2009) An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica. Hum Mutat 30: 926–933.
- 22. Mathews WR, Wang F, Eide DJ, Van Doren M (2005) Drosophila fear of intimacy Encodes a Zrt/IRT-like Protein (ZIP) Family Zinc Transporter Functionally Related to Mammalian ZIP Proteins. J Biol Chem 280: 787–795.
- 23. Yamashita S, Miyagi C, Fukada T, Kagara N, Che YS, et al. (2004) Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature 429: 298–302.
- 24. Kim I, Morimura K, Shah Y, Yang Q, Ward JM, et al. (2007) Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28: 940–946.
- 25. Yang F, Huang X, Yi T, Yen Y, Moore DD, et al. (2007) Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res 67: 863–867.
- 26. Dufner-Beattie J, Wang F, Kuo YM, Gitschier J, Eide D (2003) The Acrodermatitis Enteropathica Gene ZIP4 Encodes a Tissue-specific, Zinc-regulated Zinc Transporter in Mice. J Biol Chem 278: 33474–33481.
- 27. Weaver BP, Dufner-Beattie J, Kambe T, Andrews GK (2007) Novel zinc-responsive post-transcriptional mechanisms reciprocally regulate expression of the mouse Slc39a4 and Slc39a5 zinc transporters (Zip4 and Zip5). Biol Chem 388: 1301–1312.
- 28. Kambe T, Andrews GK (2009) Novel proteolytic processing of the ectodomain of the zinc transporter ZIP4 (Slc39a4) during zinc deficiency is inhibited by acrodermatitis enteropathica mutations. Mol Cell Biol 29: 129–139.
- 29. Kajstura M, Halicka HD, Pryjma J, Darzynkiewicz Z (2007) Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete “sub-G1” peaks on DNA content histograms. Cytometry A 71: 125–131.
- 30. Taylor KM, Vichova P, Jordan N, Hiscox S, Hendley R, et al. (2008) ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells. Endocrinology 149: 4912–4920.
- 31. Taylor KM (2008) A distinct role in breast cancer for two LIV-1 family zinc transporters. Biochem Soc Trans 36: 1247–1251.
- 32. Taylor KM, Morgan HE, Smart K, Zahari NM, Pumford S, et al. (2007) The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Mol Med 13: 396–406.
- 33. Wang FD, Kim BE, Dufner-Beattie J, Petris MJ, Andrews G, et al. (2004) Acrodermatitis enteropathica mutations affect transport activity, localization and zinc-responsive trafficking of the mouse ZIP4 zinc transporter. Hum Mol Genet 13: 563–571.
- 34. Gurusamy K (2007) Trace element concentration in primary liver cancers–a systematic review. Biol Trace Elem Res 118: 191–206.
- 35. Liuzzi JP, Guo L, Chang SM, Cousins RJ (2009) Kruppel-like factor 4 regulates adaptive expression of the zinc transporter Zip4 in mouse small intestine. Am J Physiol Gastrointest Liver Physiol 296: G517–G523.
- 36. Andrews GK (2008) Regulation and function of Zip4, the acrodermatitis enteropathica gene. Biochem Soc Trans 36: 1242–1246.
- 37. Chai FG, Truong-Tran AQ, Ho LH, Zalewski PD (1999) Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review. Immunol Cell Biol 77: 272–278.
- 38. Yan M, Song Y, Wong CP, Hardin K, Ho E (2008) Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. J Nutr 138: 667–673.
- 39. Barthel A, Ostrakhovitch EA, Walter PL, Kampkotter A, Klotz LO (2007) Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch Biochem Biophys 463: 175–182.
- 40. Jankowski-Hennig MA, Clegg MS, Daston GP, Rogers JM, Keen CL (2000) Zinc-deficient rat embryos have increased caspase 3-like activity and apoptosis. Biochem Biophys Res Commun 271: 250–256.
- 41. Wilson D, Varigos G, Ackland ML (2006) Apoptosis may underlie the pathology of zinc-deficient skin. Immunol Cell Biol 84: 28–37.
- 42. Ryu JM, Lee MY, Yun SP, Han HJ (2009) Zinc chloride stimulates DNA synthesis of mouse embryonic stem cells: involvement of PI3K/Akt, MAPKs, and mTOR. J Cell Physiol 218: 558–567.
- 43. Walter PL, Kampkotter A, Eckers A, Barthel A, Schmoll D, et al. (2006) Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions. Arch Biochem Biophys 454: 107–113.
- 44. Fukada T, Civic N, Furuichi T, Shimoda S, Mishima K, et al. (2008) The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways. PLoS ONE 3: e3642.
- 45. He N, Park K, Zhang Y, Huang J, Lu S, et al. (2008) Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth. Gastroenterology 134: 793–802.
- 46. Huang ZL, Dufner-Beattie J, Andrews GK (2006) Expression and Regulation of SLC39A Family Zinc Transporters in the Developing Mouse Intestine. Dev Biol 295: 571–579.
- 47. Dufner-Beattie J, Kuo YM, Gitschier J, Andrews GK (2004) The adaptive response to dietary zinc in mice involves the differential cellular localization and zinc-regulation of the zinc transporters ZIP4 and ZIP5. J Biol Chem 279: 49082–49090.
- 48. Andrews GK, Lee DK, Ravindra R, Lichtlen P, Sirito M, et al. (2001) The transcription factors MTF-1 and USF1 cooperate to regulate mouse metallothionein-I expression in response to the essential metal zinc in visceral endoderm cells during early development. EMBO J 20: 1114–1122.
- 49. Langmade SJ, Ravindra R, Daniels PJ, Andrews GK (2000) The transcription factor MTF-1 mediates metal regulation of the mouse ZnT1 gene. J Biol Chem 275: 34803–34809.
- 50. Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305: 1010–1013.
- 51. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868–872.
- 52. Zhang Y, Xu P, Park K, Choi Y, Moore DD, et al. (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48: 289–298.